New molecule maps cerebrovascular system Posted on 06/05/2019 by MilaPeptide developed in Brazil is capable of binding to the blood-brain barrier that protects the central nervous system and could help create novel imaging tests to diagnose Alzheimer’s and Parkinson’s. Source: EurekaAlert, https://www.eurekalert.org